A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Completed · Phase 2

Conditions studied: Obesity

In brief

This is a study to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects.

Key facts

Study ID

NCT00112021

Run by

AstraZeneca

People needed

400

Starts

2005-05-01

Expected to finish

2005-11-01

Last updated by the study team

2015-04-10

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Is obese with a body mass index (BMI) >=30 kg/m\^2 to <=50 kg/m\^2, and has been obese for at least one year before screening.
• Usually consumes at least three major meals (morning, midday, and evening) each day.

You may not qualify if…

• Is currently enrolled in a formal weight-loss program.
• Has had liposuction within 1 year before screening or is planning to have liposuction during the study.
• Has received any investigational drug within 3 months before screening.
• Has previously participated in a study using pramlintide.

Where it is running

• Research Site — Chula Vista, California, United States
• Research Site — San Diego, California, United States
• Research Site — Walnut Creek, California, United States
• Research Site — Miami, Florida, United States
• Research Site — Augusta, Georgia, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Overland Park, Kansas, United States
• Research Site — Baton Rouge, Louisiana, United States
• Research Site — Detroit, Michigan, United States
• Research Site — Edina, Minnesota, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Butte, Montana, United States
• Research Site — New York, New York, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Portland, Oregon, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Austin, Texas, United States
• Research Site — San Antonio, Texas, United States
• Research Site — Salt Lake City, Utah, United States
• Research Site — Olympia, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.